Author Archives: Marta Figueiredo PhD

Rituximab Safe, Effective in Case of Sjogren’s-related ILD

Rituximab safely and effectively treated sudden interstitial lung disease (ILD) in a 49-year-old man with undiagnosed primary Sjögren’s syndrome, a case study shows. This case adds to a growing number of reports and case series showing that rituximab lessens lung involvement in Sjögren’s patients, further supporting the usefulness…

Sjögren’s Foundation Favors COVID-19 Vaccination for Patients

The Sjögren’s Foundation is recommending that people with Sjögren’s syndrome ages 16 and older be vaccinated against  COVID-19 infection, and advices patients to talk with their healthcare provider about potential decisions and vaccination timing. The recommendation, released online in a statement, was based on safety and effectiveness…

Researchers Find Specific Autoantibody Linked to Peripheral Nerve Damage in Sjögren’s Syndrome

Researchers recently identified an autoantibody — an antibody produced against a person’s own tissue or molecule — significantly associated with the peripheral nerve damage common in Sjögren’s syndrome patients. This finding may help scientists understand the cause and development of peripheral nerve damage in this autoimmune disease, as well as…